Early changes in serum interleukin 1 receptor antagonist levels were associated with response to immune checkpoint blockade in patients with metastatic esophageal squamous cell carcinoma and colorectal cancer, and early changes in brain-derived neurotrophic factor levels were associated with response in patients with gastric cancer. Here, BDNF is linked to gastric cancer.